In vitro evidences of heparin's effects on embryo implantation and trophoblast development

Reproductive Sciences

Volumn 19, Issue 5, 2012, Pages 454-462

  Tersigni, Chiara ^a   Marana, Riccardo ^a   Santamarìa, Amparo ^b   Castellani, Roberta ^a   Scambia, Giovanni ^a   Simone, Nicoletta Di ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

heparin; in vitro; trophoblast invasion

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENOXAPARIN; HEPARIN; L SELECTIN; LOW MOLECULAR WEIGHT HEPARIN; PADGEM PROTEIN; TINZAPARIN;

ANTIPHOSPHOLIPID SYNDROME; CELL INVASION; DRUG EFFECT; DRUG MECHANISM; FETUS DEATH; HUMAN; IN VITRO STUDY; INTRAUTERINE GROWTH RETARDATION; LOW BIRTH WEIGHT; NIDATION; PREECLAMPSIA; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; SOLUTIO PLACENTAE; SPONTANEOUS ABORTION; THROMBOPHILIA; TROPHOBLAST;

ABORTION, HABITUAL; ANTIPHOSPHOLIPID SYNDROME; APOPTOSIS; EMBRYO IMPLANTATION; FEMALE; FETAL DEATH; FETAL GROWTH RETARDATION; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY OUTCOME; THROMBOPHILIA; TROPHOBLASTS;

EID: 84860448862     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719111430994     Document Type: Review

References (85)

1. Greer I, Hunt BJ. Low molecular weight heparin in pregnancy: current issues. Br J Haematol. 2005 ; 128 (5). 593-601 (Pubitemid 40343227)
2. Tincani A, Branch W, Levy RA, et al. Treatment of pregnant patients with antiphospholipid syndrome. Lupus. 2003 ; 12 (7). 524-529 (Pubitemid 36890144)
3. Empson M, Lassere M, Craig J, Scott J. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rev. 2005 ; 18 (2). CD002859
4. Brenner B, Hoffman R, Blumenfeld Z, et al. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin. Thromb Haemost. 2000 ; 83 (5). 693-697 (Pubitemid 30248516)
5. Brenner B. Enoxaparin treatment improves the gestational outcome of pregnant women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study. Blood. 2003 ; 102 (11). 43A
6. Gris JC, Mercier E, Quere I, et al. Low molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood. 2004 ; 103 (10). 3695-3699 (Pubitemid 38596284)
7. Carp H, Dolitzky M, Inbal A. Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophilia. J Thromb Haemost. 2003 ; 1 (3). 433-438
8. Kupferminc MJ, Fait G, Many A, et al. Low-molecular-weight heparin for the prevention of obstetric complications in women with thrombophilias. Hypertens Pregnancy. 2001 ; 20 (1). 35-44 (Pubitemid 32672926)
9. Grandone E, Brancaccio V, Colaizzo BS, et al. Preventing adverse obstetric outcomes in women with genetic thrombophilia. Fertil Steril. 2002 ; 78 (2). 371-375 (Pubitemid 34831739)
10. Leduc L, Dubois E, Takser L, et al. Dalteparin and low-dose aspirin in the prevention of adverse obstetric outcomes in women with inherited thrombophilia. J Obstet Gynaecol Can. 2007 ; 29 (10). 787-793
11. Paidas M, Ku DH, Triche E, Lockwood C, Arkel Y. Does heparin therapy improve pregnancy outcome in patients with thrombophilias?. J Thromb Haemost. 2004 ; 2 (7). 1194-1195 (Pubitemid 40186095)
12. Rey E, Garneau P, David M, et al. Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial. J Thromb Haemost. 2009 ; 7 (1). 58-64
13. Kupferminc M, Rimon E, Many A, Maslovitz S, Lessing JB, Gamzu R. Low molecular weight heparin versus no treatment in women with previous severe pregnancy complications and placental findings without thrombophilia. Blood Coagul Fibrinolysis. 2011 ; 22 (2). 123-126
14. Mello G, Parretti E, Fatini C, et al. Low-molecular-weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women. Hypertension. 2005 ; 45 (1). 86-91 (Pubitemid 40066419)
15. Kaandorp SP, Goddijn M, van der Post JAM, et al. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. N Engl J Med. 2010 ; 362 (17). 1586-1596
16. Greer IA. Antithrombotic therapy for recurrent miscarriage?. N Engl J Med. 2010 ; 362 (17). 1630-1631
17. Clark P, Walker ID, Langhorne P, et al. Scottish Pregnancy Intervention Study (SPIN) collaborators. SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage. Blood. 2010 ; 115 (21). 4162-4167
18. Fawzy M, Shokeir T, El-Tatongy M, Warda O, El-Refaiey AA, Mosbah A. Treatment options and pregnancy outcome in women with idiopathic recurrent miscarriage: a randomized placebo-controlled study. Arch Gynecol Obstet. 2008 ; 278 (1). 33-38
19. Smith GC, Smith MF, McNay MB, Fleming JE. First-trimester growth and the risk of low birth weight. N Engl J Med. 1998 ; 339 (25). 1817-1822 (Pubitemid 29005786)
20. Smith GC, Stenhouse EJ, Crossley JA, Aitken DA, Cameron AD, Connor JM. Early-pregnancy origins of low birth weight. Nature. 2002 ; 417 (6892). 916 (Pubitemid 34716861)
21. Genbacev OD, Prakobphol A, Foulk RA, et al. Trophoblast L-selectin-mediated adhesion at the maternal-fetal interface. Science. 2003 ; 299 (5605). 405-408 (Pubitemid 36120046)
22. Lasky LA. Selectins: interpreters of cell-specific carbohydrate information during inflammation. Science. 1992 ; 258 (5084). 964-969
23. McEver RP, Cummings RD. Role of PSGL-1 binding to selectins in leukocyte recruitment. J Clin Invest. 1997 ; 100 (11 suppl). S97 - S103
24. Rosen SD. Ligands for L-selectin: homing, inflammation, and beyond. Annu Rev Immunol. 2004 ; 22: 129-156 (Pubitemid 38680420)
25. Rosen SD. Homing in on L-selectin. J Immunol. 2006 ; 177 (1). 3-4 (Pubitemid 43939106)
26. Stevenson JL, Choi SH, Varki A. Differential metastasis inhibition by clinically relevant levels of heparins-correlation with selectin inhibition, not antithrombotic activity. Clin Cancer Res. 2005 ; 11 (19 pt 1). 7003-7011 (Pubitemid 41428760)
27. Cavallaro U, Christofori G. Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer. 2004 ; 4 (2). 118-132 (Pubitemid 38198740)
28. Xue WC, Feng HC, Tsao SW, et al. Methylation status and expression of E-cadherin and cadherin-11 in gestational trophoblastic diseases. Int J Gynecol Cancer. 2003 ; 13 (6). 879-888 (Pubitemid 38236192)
29. Li HW, Cheung AN, Tsao SW, Cheung AL, O WS. Expression of e-cadherin and beta-catenin in trophoblastic tissue in normal and pathological pregnancies. Int J Gynecol Pathol. 2003 ; 22 (1). 63-70 (Pubitemid 36014278)
30. Shih IeM, Hsu MY, Oldt RJ, Herlyn M, Gearhart JD, Kurman RJ. The role of E-cadherin in the motility and invasion of implantation site intermediate trophoblast. Placenta. 2002 ; 23 (10). 706-715 (Pubitemid 37184681)
31. Erden O, Imir A, Guvenal T, et al. Investigation of the effects of heparin and low molecular weight heparin on E-cadherin and laminin expression in rat pregnancy by immunohistochemistry. Hum Reprod. 2006 ; 21 (11). 3014-3018 (Pubitemid 44567021)
32. Quenby S, Mountfield S, Cartwright JE, Whitley GS, Vince G. Effects of low molecular weight and unfractionated heparin on trophoblast function. Obstet Gynecol. 2004 ; 104 (2). 354-361 (Pubitemid 40458884)
33. Benirschke K, Kaufmann P, Baergen RN Pathology of the Human Placenta. New York, NY: Springer ; 2006 :
34. Khong TY, De Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynecol. 1986 ; 93 (10). 1049-1049
35. Burton GJ, Jauniaux E. Placental oxidative stress: from miscarriage to preeclampsia. J Soc Gynecol Investig. 2004 ; 11 (6). 342-352 (Pubitemid 39185874)
36. Ganapathy R, Whitley GS, Cartwright JE, Dash PR, Thilaganathan B. Effect of heparin and fractionated heparin on trophoblast invasion. Hum Reprod. 2007 ; 22 (9). 2523-2527 (Pubitemid 47296606)
37. Di Simone N, Di Nicuolo F, Sanguinetti M, et al. Low-molecular weight heparin induces in vitro trophoblast invasiveness: role of matrix metalloproteinases and tissue inhibitors. Placenta. 2007 ; 28 (4). 298-304 (Pubitemid 46505937)
38. Brosens IA, Robertson WB, Dixon HG. The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Annu. 1972 ; 1: 177-191
39. Di Federico E, Genbacev O, Fisher SJ. Preeclampsia is associated with widespread apoptosis of placental cytotrophoblasts within the uterine wall. Am J Pathol. 1999 ; 155 (1). 293-301 (Pubitemid 29318727)
40. Allaire AD, Ballenger KA, Wells SR, McMahon MJ, Lessey BA. Placental apoptosis in preeclampsia. Obstet Gynecol. 2000 ; 96 (2). 271-276 (Pubitemid 30447352)
41. Naicker T, Khedun SM, Moodley J, Pijnenborg R. Quantitative analysis of trophoblast invasion in preeclampsia. Acta Obstet Gynecol Scand. 2003 ; 82 (8). 722-729 (Pubitemid 36898050)
42. Brosens JJ, Pijnenborg R, Brosens IA. The myometrial junctional zone spiral arteries in normal and abnormal pregnancies: a review of the literature. Am J Obstet Gynecol. 2002 ; 187 (5). 1416-1423 (Pubitemid 35397496)
43. Leach RE, Khalifa R, Ramirez ND, et al. Multiple roles for heparin-binding epidermal growth factor-like growth factor are suggested by its cell-specific expression during the human endometrial cycle and early placentation. J Clin Endocrinol Metab. 1999 ; 84 (9). 3355-3363 (Pubitemid 30646968)
44. Raab G, Klagsbrun M., Heparin binding EGF. growth factor. Effects of aPL on trophoblasts via inhibition of HB-EGF expression. Biochim Biophys Acta. 1997 ; 1333 (3). 179-199
45. Blotnick S, Peoples GE, Freeman MR, Eberlein TJ, Klagsbrun M. T lymphocytes synthesize and export heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor, mitogens for vascular cells and fibroblasts: differential production and release by CD4 + and CD8 + T cells. Proc Natl Acad Sci USA. 1994 ; 91 (8). 2890-2894
46. Iwamoto R, Mekada E. Heparin-binding EGF-like growth factor: a juxtacrine growth factor. Cytokine Growth Factor Rev. 2000 ; 11 (4). 335-344
47. Ongusaha PP, Kwak JC, Zwible AJ, et al. HB-EGF is a potent inducer of tumor growth and angiogenesis. Cancer Res. 2004 ; 64 (15). 5283-5290 (Pubitemid 39006548)
48. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005 ; 308 (5728). 1592-1594 (Pubitemid 40807500)
49. Leach RE, Kilburn B, Wang J, Liu Z, Romero R, Armant DR. Heparin-binding EGF-like growth factor regulates human extravillous cytotrophoblast development during conversion to the invasive phenotype. Dev Biol. 2004 ; 266 (2). 223-237 (Pubitemid 38102235)
50. Thompson SA, Higashiyama S, Wood K, et al. Characterization of sequences within heparinbinding EGF-like growth factor that mediate interaction with heparin. J Biol Chem. 1994 ; 269 (4). 2541-2549 (Pubitemid 24235748)
51. Di Simone N, Marana R, Castellani R, et al. Decreased expression of Heparin-binding epidermal growth factor-like growth factor as a newly identified pathogenic mechanism of antiphospholipid-mediated defective placentation. Arthritis Rheum. 2010 ; 62 (5). 1504-1512
52. Isaka K, Usuda S, Ito H, et al. Expression and activation of matrix metalloproteinase 2 and 9 in human trophoblasts. Placenta. 2003 ; 24 (1). 53-64 (Pubitemid 37184696)
53. Librach CL, Werb Z, Fitzgerald ML, et al. 92-kDa type IV collagenase mediates invasion of human cytotrophoblasts. J Cell Biol. 1991 ; 113 (2). 437-449 (Pubitemid 21909706)
54. Straszewski-Chavez SL, Abrahams VM, Mor G. The role of apoptosis in the regulation of trophoblast survival and differentiation during pregnancy. Endocr Rev. 2005 ; 26 (7). 877-897 (Pubitemid 41770156)
55. Smith SC, Baker PN, Symonds EM. Increased placental apoptosis in intrauterine growth restriction. Am J Obstet Gynecol. 1997 ; 177 (6). 1395-1401 (Pubitemid 28040233)
56. Leung DN, Smith SC, To KF, Sahota DS, Baker PN. Increased placental apoptosis in pregnancies complicated by preeclampsia. Am J Obstet Gynecol. 2001 ; 184 (6). 1249-1250 (Pubitemid 32434281)
57. Ishihara N, Matsuo H, Murakoshi H, Laoag-Fernandez JB, Samoto T, Maruo T. Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. Am J Obstet Gynecol. 2002 ; 186 (1). 158-166 (Pubitemid 34093758)
58. Choi HK, Choi BC, Lee SH, Kim JW, Cha KY, Baek KH. Expression of angiogenesis-and apoptosis-related genes in chorionic villi derived from recurrent pregnancy loss patients. Mol Reprod Dev. 2003 ; 66 (1). 24-31 (Pubitemid 36927783)
59. Hills FA, Abrahams VM, González-Timón B, et al. Heparin prevents programmed cell death in human trophoblast. Mol Hum Reprod. 2006 ; 12 (4). 237-243 (Pubitemid 43779075)
60. Twu C, Liu NQ, Popik W, et al. Cardiomyocytes undergo apoptosis in human immunodeficiency virus cardiomyopathy through mitochondrion-and death receptor-controlled pathways. Proc Natl Acad Sci U S A. 2002 ; 99 (22). 14386-14391 (Pubitemid 35257681)
61. Ishikawa Y, Kitamura M. Inhibition of glomerular cell apoptosis by heparin. Kidney Int. 1999 ; 56 (3). 954-963 (Pubitemid 29411722)
62. Bose P, Black S, Kadyrov M, et al. Adverse effects of lupus anticoagulant positive blood sera on placental viability can be prevented by heparin in vitro. Am J Obstet Gynecol. 2004 ; 191 (6). 2125-2131 (Pubitemid 39601524)
63. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006 ; 4 (2). 295-306
64. Woodhams BJ, Candotti G, Shaw R, Kernoff PB. Changes in coagulation and fibrinolysis during pregnancy: evidence of activation of coagulation preceding spontaneous abortion. Thromb Res. 1989 ; 55 (1). 99-107 (Pubitemid 19199170)
65. Chamley LW. Action of anticardiolipin andantibodies to beta2-glycoprotein-I on trophoblast proliferation as a mechanism for fetal death. Lancet. 1998 ; 352 (9133). 1037-1038 (Pubitemid 28438584)
66. Franklin RD, Kutteh WH. Effects of unfractionated and low molecular weight heparin on antiphospholipid antibody binding in vitro. Obstet Gynecol. 2003 ; 101 (3). 455-462 (Pubitemid 36288484)
67. Out HJ, Kooijman CD, Bruinse HW, Derksen RH. Histopathological findings in placentae from patients with intrauterine fetal death and antiphospholipid antibodies. Eur J Obstet Gynecol Reprod Biol. 1991 ; 41 (3). 179-186
68. Sebire NJ, Fox H, Backos M, Rai R, Paterson C, Regan L. Defective endovascular trophoblast invasion in primary antiphospholipid antibody syndrome-associated early pregnancy failure. Hum Reprod. 2002 ; 17 (4). 1067-1071 (Pubitemid 34411147)
69. Lyden TW, Vogt E, Ng AK, Johnson PM, Rote NS. Monoclonal antiphospholipid antibody reactivity against human placental trophoblast. J Reprod Immunol. 1992 ; 22 (1). 1-14
70. Sthoeger ZM, Mozes E, Tartakovsky B. Anti-cardiolipin antibodies induce pregnancy failure by impairing embryonic implantation. Proc Natl Acad Sci U S A. 1993 ; 90 (14). 6464-6467 (Pubitemid 23207233)
71. Di Simone N, Meroni PL, Del Papa N, et al. Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta-2-glycoprotein I. Arthritis Rheum. 2000 ; 43 (1). 140-150 (Pubitemid 30368223)
72. Ornoy A, Yacobi S, Matalon ST, et al. The effects of antiphospholipid antibodies obtained from women with SLE/APS and associated pregnancy loss on rat embryos and placental explants in culture. Lupus. 2003 ; 12 (7). 573-578 (Pubitemid 36890154)
73. Di Simone N, Ferrazzani S, Castellani R, et al. Heparin and low dose aspirin restore placental human chorionic gonadotrophin secretion abolished by antiphospholipid antibody-containing sera. Hum Reprod. 1997 ; 12 (9). 2061-2065 (Pubitemid 27462493)
74. Di Simone N, Caliandro D, Castellani R, Ferrazzani S, De Carolis S, Caruso A. Low-molecular weight heparin restores in-vitro trophoblast invasiveness and differentiation in presence of immunoglobulin G fractions obtained from patients with antiphospholipid syndrome. Hum Reprod. 1999 ; 14 (2). 489-495 (Pubitemid 29097408)
75. Guerin J, Sheng Y, Reddel S, Iverson GM, Chapman MG, Krilis SA. Heparin inhibits the binding of beta 2-glycoprotein I to phospholipids and promotes the plasmin-mediated inactivation of this blood protein. Elucidation of the consequences of the two biological events in patients with the anti-phospholipid syndrome. J Biol Chem. 2002 ; 277 (4). 2644-2649 (Pubitemid 34953290)
76. Horbach DA, van Oort E, Lisman T, Meijers JC, Derksen RH, de Groot PG. Beta2-glycoprotein I is proteolytically cleaved in vivo upon activation of fibrinolysis. Thromb Haemost. 1999 ; 81 (1). 87-95 (Pubitemid 29041656)
77. Girardi G, Berman J, Redecha P, et al. Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J Clin Invest. 2003 ; 112 (11). 1644-1654 (Pubitemid 38063722)
78. Girardi G, Redecha P, Salmon JE. Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nat Med. 2004 ; 10 (11). 1222-1226 (Pubitemid 39540439)
79. Friedrichs GS, Kilgore KS, Manley PJ, Gralinski MR, Lucchesi BR. Effect of heparin and N-acetyl heparin on ischemia/reperfusion-induced alterations in myocardial function in the rabbit isolated heart. Circ Res. 1994 ; 75 (4). 701-710 (Pubitemid 24297641)
80. Koenig A, Norgard-Sumnicht K, Lindhardt R, Varki A.. Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents. J Clin Invest. 1998 ; 101 (4). 877-889 (Pubitemid 28096085)
81. Wang L, Brown JR, Varki A, Esko JD. Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L-and P-selectins. J Clin Invest. 2002 ; 110 (1). 127-136 (Pubitemid 34743473)
82. Rops AL, van der Vlag J, Jacobs CW, et al. Heparan sulphate proteoglycans in glomerular inflammation. Kidney Int. 2004 ; 65 (3). 768-785 (Pubitemid 38251053)
83. Mollnes TE, Brekke OL, Fung M, et al. Essential role of the C5a receptor in E coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation. Blood. 2002 ; 100 (5). 1869-1877 (Pubitemid 34925168)
84. Hochart H, Jenkins PV, Smith OP, White B. Low-molecular weight and unfractionated heparins induce a downregulation of inflammation: decreased levels of proinflammatory cytokines and nuclear factor-kappaB in LPS-stimulated human monocytes. Br J Haematol. 2006 ; 133 (1). 62-67 (Pubitemid 43327199)
85. Berman J, Girardi G, Salmon JE. TNF-alpha is a critical effector and a target for therapy in antiphospholipid antibody-induced pregnancy loss. J Immunol. 2005 ; 174 (1). 485-490 (Pubitemid 40007438)